Literature DB >> 19439735

A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein.

Nana Ueffing1, Kusum K Singh, Andrea Christians, Christoph Thorns, Alfred C Feller, Florian Nagl, Falko Fend, Sebastian Heikaus, Alexander Marx, Rainer B Zotz, Joachim Brade, Wolfgang A Schulz, Klaus Schulze-Osthoff, Ingo Schmitz, Christian Schwerk.   

Abstract

The cellular FLICE-inhibitory protein (c-FLIP) is a modulator of death receptor-mediated apoptosis and plays a major role in T- and B-cell homeostasis. Three different isoforms have been described on the protein level, including the long form c-FLIP(L) as well as 2 short forms, c-FLIP(S) and the recently identified c-FLIP(R). The mechanisms controlling c-FLIP isoform production are largely unknown. Here, we identified by sequence comparison in several mammals that c-FLIP(R) and not the widely studied c-FLIP(S) is the evolutionary ancestral short c-FLIP protein. Unexpectedly, the decision for production of either c-FLIP(S) or c-FLIP(R) in humans is defined by a single nucleotide polymorphism in a 3' splice site of the c-FLIP gene (rs10190751A/G). Whereas an intact splice site directs production of c-FLIP(S), the splice-dead variant causes production of c-FLIP(R). Interestingly, due to differences in protein translation rates, higher amounts of c-FLIP(S) protein compared with c-FLIP(R) are produced. Investigation of diverse human cell lines points to an increased frequency of c-FLIP(R) in transformed B-cell lines. A comparison of 183 patients with follicular lymphoma and 233 population controls revealed an increased lymphoma risk associated with the rs10190751 A genotype causing c-FLIP(R) expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439735     DOI: 10.1182/blood-2009-02-204230

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.

Authors:  Xue Wei Meng; Michael P Heldebrant; Karen S Flatten; David A Loegering; Haiming Dai; Paula A Schneider; Timothy S Gomez; Kevin L Peterson; Sergey A Trushin; Allan D Hess; B Douglas Smith; Judith E Karp; Daniel D Billadeau; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

2.  Antioxidant c-FLIP inhibits Fas ligand-induced NF-kappaB activation in a phosphatidylinositol 3-kinase/Akt-dependent manner.

Authors:  Anand Krishnan V Iyer; Neelam Azad; Siera Talbot; Christian Stehlik; Bin Lu; Liying Wang; Yon Rojanasakul
Journal:  J Immunol       Date:  2011-08-19       Impact factor: 5.422

Review 3.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

4.  Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin.

Authors:  Xiang Li; Feng Xu; Ekapun Karoopongse; A Mario Marcondes; Kayoung Lee; Kris V Kowdley; Carol H Miao; Grant D Trobridge; Jean S Campbell; H Joachim Deeg
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-22       Impact factor: 5.742

Review 5.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

6.  The role of c-FLIP splice variants in urothelial tumours.

Authors:  F Ewald; N Ueffing; L Brockmann; C Hader; T Telieps; M Schuster; W A Schulz; I Schmitz
Journal:  Cell Death Dis       Date:  2011-12-22       Impact factor: 8.469

7.  Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.

Authors:  Ahmad R Safa; Karen E Pollok
Journal:  Cancers (Basel)       Date:  2011-06       Impact factor: 6.639

8.  Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity.

Authors:  Lata Chauhan; Gregory D Jenkins; Neha Bhise; Tanya Feldberg; Taraswi Mitra-Ghosh; Brooke L Fridley; Jatinder K Lamba
Journal:  BMC Genomics       Date:  2015-06-30       Impact factor: 3.969

9.  Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines.

Authors:  Therese Bredholt; Elizabeth Ao Dimba; Hanne R Hagland; Line Wergeland; Jørn Skavland; Kjell O Fossan; Karl J Tronstad; Anne C Johannessen; Olav K Vintermyr; Bjørn T Gjertsen
Journal:  Mol Cancer       Date:  2009-11-13       Impact factor: 27.401

Review 10.  Lesser-Known Molecules in Ovarian Carcinogenesis.

Authors:  Ludmila Lozneanu; Elena Cojocaru; Simona Eliza Giuşcă; Alexandru Cărăuleanu; Irina-Draga Căruntu
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.